About Katie Ellias
Form D filings for Veralox Therapeutics from 2021 to 2023 list Katie Ellias as director.
Katie Ellias first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Katie Ellias in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Katie Ellias works with at each company, as listed on that company's latest Form D.
Veralox Therapeutics Inc. · Form D, Jun 21, 2023
MK
Megan Krench
Director
AM
Alex Martin
Director
BS
Benjamin Scruggs
Director
JS
Jamie Stiff
Director
JM
Jonathan Mow
Chief Executive Officer and director